EyePoint PharmaceuticalsEYPT
Market Cap: $427M
About: EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Employees: 144
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
40% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 45
0.91% less ownership
Funds ownership: 113.05% [Q1] → 112.14% (-0.91%) [Q2]
7% less funds holding
Funds holding: 162 [Q1] → 150 (-12) [Q2]
32% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 37
40% less funds holding in top 10
Funds holding in top 10: 5 [Q1] → 3 (-2) [Q2]
43% less call options, than puts
Call options by funds: $6.89M | Put options by funds: $12.1M
56% less capital invested
Capital invested by funds: $1.16B [Q1] → $508M (-$656M) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Jefferies Kambiz Yazdi 0% 1-year accuracy 0 / 4 met price target | 88%upside $15 | Buy Initiated | 28 Aug 2024 |
JP Morgan Tessa Romero 22% 1-year accuracy 4 / 18 met price target | 264%upside $29 | Overweight Maintained | 13 Aug 2024 |
Chardan Capital Daniil Gataulin 18% 1-year accuracy 3 / 17 met price target | 251%upside $28 | Buy Maintained | 28 Jun 2024 |
HC Wainwright & Co. Yi Chen 32% 1-year accuracy 44 / 139 met price target | 276%upside $30 | Buy Reiterated | 27 Jun 2024 |
Financial journalist opinion
Based on 4 articles about EYPT published over the past 30 days